Catalogue: Drug target reagents
5,000+ drug target reagents for antibody, small molecule drug discovery and development, including immune checkpoints, cytokines and kinases.
To support basic research, translational research, and drug development, Sino Biological has developed a panel of reagents supporting multiple therapeutic areas, including oncology, respiratory diseases, autoimmune diseases, and infective diseases.
Related content from this organisation
- Whitepaper: Recombinant protein expression using a BEVS
- Sino Biological and Ainnocence partner to offer next-generation antibody development CRO services
- Sino Biological invests over 200M RMB to establish new subsidiaries in Taizhou and Suzhou, China
- Whitepaper: In-depth look into anti-idiotype antibodies
- Article: Bispecific antibodies: Rising stars in antibody therapeutics